Tenax Therapeutics, Inc. develops and commercializes pharmaceutical products containing imatinib for the treatment of pulmonary arterial hypertension in the United States. The company develops TNX-101 (IV), TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is based in Chapel Hill, North Carolina.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2024-05-14 |
2024-03 |
-2.4 |
-3.12 |
-0.72 |
-30.00% |
2024-04-01 |
2023-12 |
-8.15 |
N/A |
N/A |
N/A |
2023-11-13 |
2023-09 |
-7.2 |
-6.4 |
0.8 |
11.11% |
2023-08-14 |
2023-06 |
0 |
N/A |
N/A |
N/A |
2023-05-15 |
2023-03 |
0 |
N/A |
N/A |
N/A |
2023-03-30 |
2022-12 |
-2.65 |
N/A |
N/A |
N/A |
Date |
Firm |
Action |
From |
To |
2023-03-06 |
Roth MKM |
Upgrade |
|
Buy |
Date |
Name |
Relation |
Quantity |
Description |
2020-09-07 |
ARMISTICE CAPITAL L.L.C. |
Beneficial Owner of more than 10% of a Class of Security |
0.00 |
Purchase |
2020-05-17 |
BLANCK RONALD RAY |
Director |
6.06K |
Purchase |
2021-06-10 |
DAVIDSON MICHAEL H |
Director |
606.65K |
Conversion of Exercise of derivative security |
2022-08-10 |
DOOGAN DECLAN |
Director and Beneficial Owner of more than 10% of a Class of Security |
0.00 |
Stock Gift |
2016-04-28 |
JEBSEN MICHAEL B |
Chief Financial Officer |
68.41K |
Stock Award(Grant) |
2017-03-14 |
KELLEY JOHN P |
Chief Executive Officer |
1.28M |
Stock Award(Grant) |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Corient Private Wealth LLC |
191.46K |
57.44K |
0.80% |
2023-06-29 |
State Street Corporation |
95.12K |
28.54K |
0.40% |
2023-06-29 |
Blackrock Inc. |
23.92K |
7.18K |
0.10% |
2023-06-29 |
LPL Financial LLC |
20.00K |
6.00K |
0.08% |
2023-06-29 |
Two Sigma Securities, LLC |
19.76K |
5.93K |
0.08% |
2023-06-29 |
Millennium Management Llc |
16.56K |
4.97K |
0.07% |
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Vanguard Extended Market Index Fund |
8.69K |
2.61K |
0.04% |
2023-05-30 |
Fidelity NASDAQ Composite Index Fund |
1.52K |
551.00 |
0.01% |
Split |
Date |
1 : 80 |
2024-01-03 |
1 : 20 |
2023-01-05 |
1 : 20 |
2018-02-26 |
0.05 : 1 |
2013-05-13 |
0.06667 : 1 |
2009-11-09 |